CIK: 1738782 - Address: C/O Novabay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1150, Emeryville, CA 94608
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/7/22 16:55
12/6/22
NBYNovabay Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKunin JeffreyCAOP,DERMAdS01.8100-1000I
12/5/22 17:30
11/21/22
NBYNovabay Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKunin JeffreyCAOP,DERMAdS.a-132.100-6-1000I
11/23/22 16:15
11/21/22
NBYNovabay Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKunin JeffreyCAOP,DERMAdS-132.100-6-1000I
9/16/22 18:26
9/14/22
NBYNovabay Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKunin JeffreyCAOP,DERMAdS-460.15820-291-58209I
12/7/21 17:46
12/3/21
NBYNovabay Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKunin JeffreyCAOP,DERMAdP470.4625010226500I
12/6/21 16:31
12/2/21
NBYNovabay Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKunin JeffreyCAOP,DERMAdP1250.47600262193398I
12/3/21 16:30
12/1/21
NBYNovabay Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKunin JeffreyCAOP,DERMAdP70.490001512136I
12/2/21 16:30
11/30/21
NBYNovabay Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKunin JeffreyCAOP,DERMAdP140.460003033121I
11/24/21 16:46
11/22/21
NBYNovabay Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKunin JeffreyCAOP,DERMAdP.m420.4594091New91I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact